Herpesvirus gB: A finely tuned fusion machine

Viruses

Volumn 7, Issue 12, 2015, Pages 6552-6569

  Cooper, Rebecca S ^a   Heldwein, Ekaterina E ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell entry; Electron microscopy; Electron tomography; Glycoproteins; Herpesviruses; Membrane fusion; Virions; X ray crystallography

Indexed keywords

GLYCOPROTEIN B; GLYCOPROTEIN D; GLYCOPROTEIN H; GLYCOPROTEIN L; HETERODIMER; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN; GLYCOPROTEIN B, HERPES SIMPLEX VIRUS TYPE 2; GLYCOPROTEIN B, HUMAN HERPESVIRUS 1; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; CELL FUSION; ENZYME ACTIVE SITE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPESVIRIDAE; MEMBRANE FUSION; NONHUMAN; PROTEIN PROTEIN INTERACTION; REGULATORY SEQUENCE; REVIEW; VIRUS CELL INTERACTION; VIRUS ENTRY; HUMAN; METABOLISM; PHYSIOLOGY;

HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 84949942572     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v7122957     Document Type: Review

References (126)

1. Harrison, S.C. Viral membrane fusion. Virology 2015, 479, 498–507. [CrossRef] [PubMed]
2. Heldwein, E.E.; Krummenacher, C. Entry of herpesviruses into mammalian cells. Cell. Mol. Life Sci. 2008, 65, 1653–1668. [CrossRef] [PubMed]
3. Gianni, T.; Salvioli, S.; Chesnokova, L.S.; Hutt-Fletcher, L.M.; Campadelli-Fiume, G. Alphavbeta6- and alphavbeta8-integrins serve as interchangeable receptors for HSV gH/gL to promote endocytosis and activation of membrane fusion. PLoS Pathog. 2013, 9. [CrossRef] [PubMed]
4. Gianni, T.; Massaro, R.; Campadelli-Fiume, G. Dissociation of HSV gL from gH by alphavbeta6- or alphavbeta8-integrin promotes gH activation and virus entry. Proc. Natl Acad Sci. USA 2015, 112, E3901–E3910. [CrossRef] [PubMed]
5. Satoh, T.; Arii, J.; Suenaga, T.; Wang, J.; Kogure, A.; Uehori, J.; Arase, N.; Shiratori, I.; Tanaka, S.; Kawaguchi, Y., et al. PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell 2008, 132, 935–944. [CrossRef] [PubMed]
6. Li, Y.; Modis, Y. A novel membrane fusion protein family in Flaviviridae? Trends Microbiol. 2014, 22, 176–182. [CrossRef] [PubMed]
7. Lamb, R.A.; Jardetzky, T.S. Structural basis of viral invasion: Lessons from paramyxovirus F. Curr. Opin. Struct. Biol. 2007, 17, 427–436. [CrossRef] [PubMed]
8. Lee, J.E.; Fusco, M.L.; Hessell, A.J.; Oswald, W.B.; Burton, D.R.; Saphire, E.O. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 2008, 454, 177–182. [CrossRef] [PubMed]
9. Modis, Y. Class II fusion proteins. Adv. Exp. Med. Biol. 2013, 790, 150–166. [PubMed]
10. Kielian, M. Class II virus membrane fusion proteins. Virology 2006, 344, 38–47. [CrossRef] [PubMed]
11. Li, L.; Lok, S.M.; Yu, I.M.; Zhang, Y.; Kuhn, R.J.; Chen, J.; Rossmann, M.G. The flavivirus precursor membrane-envelope protein complex: Structure and maturation. Science 2008, 319, 1830–1834. [CrossRef] [PubMed]
12. Voss, J.E.; Vaney, M.C.; Duquerroy, S.; Vonrhein, C.; Girard-Blanc, C.; Crublet, E.; Thompson, A.; Bricogne, G.; Rey, F.A. Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature 2010, 468, 709–712. [CrossRef] [PubMed]
13. Backovic, M.; Jardetzky, T.S. Class III viral membrane fusion proteins. Curr. Opin. Struct. Biol. 2009, 19, 189–196. [CrossRef] [PubMed]
14. Roche, S.; Rey, F.A.; Gaudin, Y.; Bressanelli, S. Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G. Science 2007, 315, 843–848. [CrossRef] [PubMed]
15. Roche, S.; Bressanelli, S.; Rey, F.A.; Gaudin, Y. Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G. Science 2006, 313, 187–191. [CrossRef] [PubMed]
16. Zelus, B.D.; Schickli, J.H.; Blau, D.M.; Weiss, S.R.; Holmes, K.V. Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37 degrees C either by soluble murine CEACAM1 receptors or by pH 8. J. Virol. 2003, 77, 830–840. [CrossRef] [PubMed]
17. Matsuyama, S.; Taguchi, F. Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysis. J. Virol. 2009, 83, 11133–11141. [CrossRef] [PubMed]
18. Bullough, P.A.; Hughson, F.M.; Skehel, J.J.; Wiley, D.C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 1994, 371, 37–43. [CrossRef] [PubMed]
19. Kadlec, J.; Loureiro, S.; Abrescia, N.G.; Stuart, D.I.; Jones, I.M. The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines. Nat. Struct. Mol. Biol. 2008, 15, 1024–1030. [CrossRef] [PubMed]
20. Mair, C.M.; Meyer, T.; Schneider, K.; Huang, Q.; Veit, M.; Herrmann, A. A histidine residue of the influenza virus hemagglutinin controls the pH dependence of the conformational change mediating membrane fusion. J. Virol. 2014, 88, 13189–13200. [CrossRef] [PubMed]
21. Kampmann, T.; Mueller, D.S.; Mark, A.E.; Young, P.R.; Kobe, B. The role of histidine residues in low-pH-mediated viral membrane fusion. Structure 2006, 14, 1481–1487. [CrossRef] [PubMed]
22. Roche, S.; Albertini, A.A.; Lepault, J.; Bressanelli, S.; Gaudin, Y. Structures of vesicular stomatitis virus glycoprotein: Membrane fusion revisited. Cell. Mol. Life Sci. 2008, 65, 1716–1728. [CrossRef] [PubMed]
23. Wilen, C.B.; Tilton, J.C.; Doms, R.W. Molecular mechanisms of HIV entry. Adv. Exp. Med. Biol. 2012, 726, 223–242. [PubMed]
24. Mothes, W.; Boerger, A.L.; Narayan, S.; Cunningham, J.M.; Young, J.A. Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell 2000, 103, 679–689. [CrossRef]
25. Chandran, K.; Sullivan, N.J.; Felbor, U.; Whelan, S.P.; Cunningham, J.M. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 2005, 308, 1643–1645. [CrossRef] [PubMed]
26. Cote, M.; Misasi, J.; Ren, T.; Bruchez, A.; Lee, K.; Filone, C.M.; Hensley, L.; Li, Q.; Ory, D.; Chandran, K., et al. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 2011, 477, 344–348. [CrossRef] [PubMed]
27. Lamb, R.A.; Paterson, R.G.; Jardetzky, T.S. Paramyxovirus membrane fusion: Lessons from the F and HN atomic structures. Virology 2006, 344, 30–37. [CrossRef] [PubMed]
28. Eisenberg, R.J.; Atanasiu, D.; Cairns, T.M.; Gallagher, J.R.; Krummenacher, C.; Cohen, G.H. Herpes virus fusion and entry: A story with many characters. Viruses 2012, 4, 800–832. [CrossRef] [PubMed]
29. Spear, P.G. Herpes simplex virus: Receptors and ligands for cell entry. Cell Microbiol. 2004, 6, 401–410. [CrossRef] [PubMed]
30. Tiwari, V.; O’Donnell, C.; Copeland, R.J.; Scarlett, T.; Liu, J.; Shukla, D. Soluble 3-O-sulfated heparan sulfate can trigger herpes simplex virus type 1 entry into resistant Chinese hamster ovary (CHO-K1) cells. J. Gen. Virol. 2007, 88, 1075–1079. [CrossRef] [PubMed]
31. Lazear, E.; Carfi, A.; Whitbeck, J.C.; Cairns, T.M.; Krummenacher, C.; Cohen, G.H.; Eisenberg, R.J. Engineered disulfide bonds in herpes simplex virus type 1 gD separate receptor binding from fusion initiation and viral entry. J. Virol. 2008, 82, 700–709. [CrossRef] [PubMed]
32. Krummenacher, C.; Supekar, V.M.; Whitbeck, J.C.; Lazear, E.; Connolly, S.A.; Eisenberg, R.J.; Cohen, G.H.; Wiley, D.C.; Carfi, A. Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry. EMBO J. 2005, 24, 4144–4153. [CrossRef] [PubMed]
33. Atanasiu, D.; Saw, W.T.; Cohen, G.H.; Eisenberg, R.J. Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gD, gH/gL, and gB. J. Virol. 2010, 84, 12292–12299. [CrossRef] [PubMed]
34. Atanasiu, D.; Cairns, T.M.; Whitbeck, J.C.; Saw, W.T.; Rao, S.; Eisenberg, R.J.; Cohen, G.H. Regulation of herpes simplex virus gB-induced cell-cell fusion by mutant forms of gH/gL in the absence of gD and cellular receptors. MBio 2013, 4. [CrossRef] [PubMed]
35. Gianni, T.; Amasio, M.; Campadelli-Fiume, G. Herpes simplex virus gD forms distinct complexes with fusion executors gB and gH/gL in part through the C-terminal profusion domain. J. Biol. Chem 2009, 284, 17370–17382. [CrossRef] [PubMed]
36. Atanasiu, D.; Whitbeck, J.C.; Cairns, T.M.; Reilly, B.; Cohen, G.H.; Eisenberg, R.J. Bimolecular complementation reveals that glycoproteins gB and gH/gL of herpes simplex virus interact with each other during cell fusion. Proc. Natl. Acad. Sci. USA 2007, 104, 18718–18723. [CrossRef] [PubMed]
37. Atanasiu, D.; Whitbeck, J.C.; de Leon, M.P.; Lou, H.; Hannah, B.P.; Cohen, G.H.; Eisenberg, R.J. Bimolecular complementation defines functional regions of herpes simplex virus gB that are involved with gH/gL as a necessary step leading to cell fusion. J. Virol. 2010, 84, 3825–3834. [CrossRef] [PubMed]
38. Chowdary, T.K.; Cairns, T.M.; Atanasiu, D.; Cohen, G.H.; Eisenberg, R.J.; Heldwein, E.E. Crystal structure of the conserved herpesvirus fusion regulator complex gH-gL. Nat. Struct. Mol. Biol. 2010, 17, 882–888. [CrossRef] [PubMed]
39. Li, Q.; Spriggs, M.K.; Kovats, S.; Turk, S.M.; Comeau, M.R.; Nepom, B.; Hutt-Fletcher, L.M. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J. Virol. 1997, 71, 4657–4662. [PubMed]
40. Mullen, M.M.; Haan, K.M.; Longnecker, R.; Jardetzky, T.S. Structure of the Epstein-Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1. Mol. Cell 2002, 9, 375–385. [CrossRef]
41. Chesnokova, L.S.; Hutt-Fletcher, L.M. Fusion of Epstein-Barr virus with epithelial cells can be triggered by αvβ5 in addition to αvβ6 and αvβ8, and integrin binding triggers a conformational change in glycoproteins gHgL. J. Virol. 2011, 85, 13214–13223. [CrossRef] [PubMed]
42. Chesnokova, L.S.; Nishimura, S.L.; Hutt-Fletcher, L.M. Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins αvβ6 or αvβ8. Proc. Natl. Acad. Sci. USA 2009, 106, 20464–20469. [CrossRef] [PubMed]
43. Vanarsdall, A.L.; Chase, M.C.; Johnson, D.C. Human cytomegalovirus glycoprotein gO complexes with gH/gL, promoting interference with viral entry into human fibroblasts but not entry into epithelial cells. J. Virol. 2011, 85, 11638–11645. [CrossRef] [PubMed]
44. Wille, P.T.; Knoche, A.J.; Nelson, J.A.; Jarvis, M.A.; Johnson, D.C. A human cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells. J. Virol. 2010, 84, 2585–2596. [CrossRef] [PubMed]
45. Wang, D.; Shenk, T. Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc. Natl. Acad. Sci. USA 2005, 102, 18153–18158. [CrossRef] [PubMed]
46. Ryckman, B.J.; Jarvis, M.A.; Drummond, D.D.; Nelson, J.A.; Johnson, D.C. Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J. Virol. 2006, 80, 710–722. [CrossRef] [PubMed]
47. Zhou, M.; Lanchy, J.M.; Ryckman, B.J. Human cytomegalovirus gH/gL/gO promotes the fusion step of entry into all cell types, whereas gH/gL/UL128–131 broadens virus tropism through a distinct mechanism. J. Virol. 2015, 89, 8999–9009. [CrossRef] [PubMed]
48. Laquerre, S.; Argnani, R.; Anderson, D.B.; Zucchini, S.; Manservigi, R.; Glorioso, J.C. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J. Virol. 1998, 72, 6119–6130. [PubMed]
49. Stampfer, S.D.; Lou, H.; Cohen, G.H.; Eisenberg, R.J.; Heldwein, E.E. Structural basis of local, pH-dependent conformational changes in glycoprotein B from herpes simplex virus type 1. J. Virol. 2010, 84, 12924–12933. [CrossRef] [PubMed]
50. Heldwein, E.E.; Lou, H.; Bender, F.C.; Cohen, G.H.; Eisenberg, R.J.; Harrison, S.C. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 2006, 313, 217–220. [CrossRef] [PubMed]
51. Backovic, M.; Longnecker, R.; Jardetzky, T.S. Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B. Proc. Natl. Acad. Sci. USA 2009, 106, 2880–2885. [CrossRef] [PubMed]
52. Chandramouli, S.; Ciferri, C.; Nikitin, P.A.; Calo, S.; Gerrein, R.; Balabanis, K.; Monroe, J.; Hebner, C.; Lilja, A.E.; Settembre, E.C., et al. Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody. Nat. Commun. 2015, 6. [CrossRef] [PubMed]
53. Burke, H.G.; Heldwein, E.E. Crystal structure of the human cytomegalovirus glycoprotein B. PLoS Pathog. 2015, 11. [CrossRef] [PubMed]
54. Atanasiu, D.; Saw, W.T.; Gallagher, J.R.; Hannah, B.P.; Matsuda, Z.; Whitbeck, J.C.; Cohen, G.H.; Eisenberg, R.J. Dual split protein-based fusion assay reveals that mutations to herpes simplex virus (HSV) glycoprotein gB alter the kinetics of cell-cell fusion induced by HSV entry glycoproteins. J. Virol. 2013, 87, 11332–11345. [CrossRef] [PubMed]
55. Gallagher, J.R.; Atanasiu, D.; Saw, W.T.; Paradisgarten, M.J.; Whitbeck, J.C.; Eisenberg, R.J.; Cohen, G.H. Functional fluorescent protein insertions in herpes simplex virus gB report on gB conformation before and after execution of membrane fusion. PLoS Pathog. 2014, 10. [CrossRef] [PubMed]
56. Bender, F.C.; Samanta, M.; Heldwein, E.E.; de Leon, M.P.; Bilman, E.; Lou, H.; Whitbeck, J.C.; Eisenberg, R.J.; Cohen, G.H. Antigenic and mutational analyses of herpes simplex virus glycoprotein B reveal four functional regions. J. Virol. 2007, 81, 3827–3841. [CrossRef] [PubMed]
57. Cairns, T.M.; Fontana, J.; Huang, Z.Y.; Whitbeck, J.C.; Atanasiu, D.; Rao, S.; Shelly, S.S.; Lou, H.; Ponce de Leon, M.; Steven, A.C., et al. Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B. J. Virol. 2014, 88, 2677–2689. [CrossRef] [PubMed]
58. McLellan, J.S.; Chen, M.; Leung, S.; Graepel, K.W.; Du, X.; Yang, Y.; Zhou, T.; Baxa, U.; Yasuda, E.; Beaumont, T., et al. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science 2013, 340, 1113–1117. [CrossRef] [PubMed]
59. McLellan, J.S.; Yang, Y.; Graham, B.S.; Kwong, P.D. Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes. J. Virol. 2011, 85, 7788–7796. [CrossRef] [PubMed]
60. McLellan, J.S. Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein. Curr. Opin. Virol. 2015, 11, 70–75. [CrossRef] [PubMed]
61. Vitu, E.; Sharma, S.; Stampfer, S.D.; Heldwein, E.E. Extensive mutagenesis of the HSV-1 gB ectodomain reveals remarkable stability of its postfusion form. J. Mol. Biol. 2013, 425, 2056–2071. [CrossRef] [PubMed]
62. Yin, H.S.; Paterson, R.G.; Wen, X.; Lamb, R.A.; Jardetzky, T.S. Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein. Proc. Natl. Acad. Sci. USA 2005, 102, 9288–9293. [CrossRef] [PubMed]
63. Chen, J.; Wharton, S.A.; Weissenhorn, W.; Calder, L.J.; Hughson, F.M.; Skehel, J.J.; Wiley, D.C. A soluble domain of the membrane-anchoring chain of influenza virus hemagglutinin (HA2) folds in Escherichia coli into the low-pH-induced conformation. Proc. Natl. Acad. Sci. USA 1995, 92, 12205–12209. [CrossRef] [PubMed]
64. Yin, H.S.; Wen, X.; Paterson, R.G.; Lamb, R.A.; Jardetzky, T.S. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 2006, 439, 38–44. [CrossRef] [PubMed]
65. Sissoeff, L.; Mousli, M.; England, P.; Tuffereau, C. Stable trimerization of recombinant rabies virus glycoprotein ectodomain is required for interaction with the p75NTR receptor. J. Gen. Virol. 2005, 86, 2543–2552. [CrossRef] [PubMed]
66. Stevens, J.; Corper, A.L.; Basler, C.F.; Taubenberger, J.K.; Palese, P.; Wilson, I.A. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 2004, 303, 1866–1870. [CrossRef] [PubMed]
67. Wanas, E.; Efler, S.; Ghosh, K.; Ghosh, H.P. Mutations in the conserved carboxy-terminal hydrophobic region of glycoprotein gB affect infectivity of herpes simplex virus. J. Gen. Virol. 1999, 80, 3189–3198. [CrossRef] [PubMed]
68. Zhang, X.; Ge, P.; Yu, X.; Brannan, J.M.; Bi, G.; Zhang, Q.; Schein, S.; Zhou, Z.H. Cryo-EM structure of the mature dengue virus at 3.5-A resolution. Nat. Struct. Mol. Biol. 2013, 20, 105–110. [CrossRef] [PubMed]
69. Modis, Y.; Ogata, S.; Clements, D.; Harrison, S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature 2004, 427, 313–319. [CrossRef] [PubMed]
70. Maurer, U.E.; Zeev-Ben-Mordehai, T.; Pandurangan, A.P.; Cairns, T.M.; Hannah, B.P.; Whitbeck, J.C.; Eisenberg, R.J.; Cohen, G.H.; Topf, M.; Huiskonen, J.T., et al. The structure of herpesvirus fusion glycoprotein B-bilayer complex reveals the protein-membrane and lateral protein-protein interaction. Structure 2013, 21, 1396–1405. [CrossRef] [PubMed]
71. Shelly, S.S.; Cairns, T.M.; Whitbeck, J.C.; Lou, H.; Krummenacher, C.; Cohen, G.H.; Eisenberg, R.J. The membrane-proximal region (MPR) of herpes simplex virus gB regulates association of the fusion loops with lipid membranes. MBio 2012, 3. [CrossRef] [PubMed]
72. Hannah, B.P.; Cairns, T.M.; Bender, F.C.; Whitbeck, J.C.; Lou, H.; Eisenberg, R.J.; Cohen, G.H. Herpes simplex virus glycoprotein B associates with target membranes via its fusion loops. J. Virol. 2009, 83, 6825–6836. [CrossRef] [PubMed]
73. Li, Z.; Blissard, G.W. The pre-transmembrane domain of the Autographa californica multicapsid nucleopolyhedrovirus GP64 protein is critical for membrane fusion and virus infectivity. J. Virol. 2009, 83, 10993–11004. [CrossRef] [PubMed]
74. Jeetendra, E.; Ghosh, K.; Odell, D.; Li, J.; Ghosh, H.P.; Whitt, M.A. The membrane-proximal region of vesicular stomatitis virus glycoprotein G ectodomain is critical for fusion and virus infectivity. J. Virol. 2003, 77, 12807–12818. [CrossRef] [PubMed]
75. Jeetendra, E.; Robison, C.S.; Albritton, L.M.; Whitt, M.A. The membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion potentiator and can induce hemifusion. J. Virol. 2002, 76, 12300–12311. [CrossRef] [PubMed]
76. Zheng, Z.; Maidji, E.; Tugizov, S.; Pereira, L. Mutations in the carboxyl-terminal hydrophobic sequence of human cytomegalovirus glycoprotein B alter transport and protein chaperone binding. J. Virol. 1996, 70, 8029–8040. [PubMed]
77. Rasile, L.; Ghosh, K.; Raviprakash, K.; Ghosh, H.P. Effects of deletions in the carboxy-terminal hydrophobic region of herpes simplex virus glycoprotein gB on intracellular transport and membrane anchoring. J. Virol. 1993, 67, 4856–4866. [PubMed]
78. Lin, E.; Spear, P.G. Random linker-insertion mutagenesis to identify functional domains of herpes simplex virus type 1 glycoprotein B. Proc. Natl. Acad. Sci. USA 2007, 104, 13140–13145. [CrossRef] [PubMed]
79. Gilbert, R.; Ghosh, K.; Rasile, L.; Ghosh, H.P. Membrane anchoring domain of herpes simplex virus glycoprotein gB is sufficient for nuclear envelope localization. J. Virol. 1994, 68, 2272–2285. [PubMed]
80. Arkin, I.T.; Brunger, A.T. Statistical analysis of predicted transmembrane α-helices. Biochim. Biophys. Acta 1998, 1429, 113–128. [CrossRef]
81. Engelman, D.M.; Steitz, T.A.; Goldman, A. Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins. Annu. Rev. Biophys. Biophys. Chem. 1986, 15, 321–353. [CrossRef] [PubMed]
82. Jones, N.A.; Geraghty, R.J. Fusion activity of lipid-anchored envelope glycoproteins of herpes simplex virus type 1. Virology 2004, 324, 213–228. [CrossRef] [PubMed]
83. Kemble, G.W.; Danieli, T.; White, J.M. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell 1994, 76, 383–391. [CrossRef]
84. Odell, D.; Wanas, E.; Yan, J.; Ghosh, H.P. Influence of membrane anchoring and cytoplasmic domains on the fusogenic activity of vesicular stomatitis virus glycoprotein G. J. Virol. 1997, 71, 7996–8000. [PubMed]
85. Markosyan, R.M.; Cohen, F.S.; Melikyan, G.B. The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores. Mol. Biol. Cell 2000, 11, 1143–1152. [CrossRef] [PubMed]
86. Bissonnette, M.L.; Donald, J.E.; DeGrado, W.F.; Jardetzky, T.S.; Lamb, R.A. Functional analysis of the transmembrane domain in paramyxovirus F protein-mediated membrane fusion. J. Mol. Biol. 2009, 386, 14–36. [CrossRef] [PubMed]
87. Li, Z.; Blissard, G.W. The Autographa californica multicapsid nucleopolyhedrovirus GP64 protein: Analysis of transmembrane domain length and sequence requirements. J. Virol. 2009, 83, 4447–4461. [CrossRef] [PubMed]
88. Miyauchi, K.; Komano, J.; Yokomaku, Y.; Sugiura, W.; Yamamoto, N.; Matsuda, Z. Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion. J. Virol. 2005, 79, 4720–4729. [CrossRef] [PubMed]
89. Cleverley, D.Z.; Lenard, J. The transmembrane domain in viral fusion: Essential role for a conserved glycine residue in vesicular stomatitis virus G protein. Proc. Natl. Acad. Sci. USA 1998, 95, 3425–3430. [CrossRef] [PubMed]
90. Lee, A.G. Lipid-protein interactions in biological membranes: A structural perspective. Biochim. Biophys. Acta 2003, 1612, 1–40. [CrossRef]
91. Ulmschneider, M.B.; Sansom, M.S. Amino acid distributions in integral membrane protein structures. Biochim. Biophys. Acta 2001, 1512, 1–14. [CrossRef]
92. Armstrong, R.T.; Kushnir, A.S.; White, J.M. The transmembrane domain of influenza hemagglutinin exhibits a stringent length requirement to support the hemifusion to fusion transition. J. Cell Biol. 2000, 151, 425–437. [CrossRef] [PubMed]
93. Pace, C.N.; Scholtz, J.M. A helix propensity scale based on experimental studies of peptides and proteins. Biophys. J. 1998, 75, 422–427. [CrossRef]
94. Yi, M.; Cross, T.A.; Zhou, H.X. Conformational heterogeneity of the M2 proton channel and a structural model for channel activation. Proc. Natl. Acad. Sci. USA 2009, 106, 13311–13316. [CrossRef] [PubMed]
95. Quint, S.; Widmaier, S.; Minde, D.; Hornburg, D.; Langosch, D.; Scharnagl, C. Residue-specific side-chain packing determines the backbone dynamics of transmembrane model helices. Biophys. J. 2010, 99, 2541–2549. [CrossRef] [PubMed]
96. Liao, M.; Kielian, M. The conserved glycine residues in the transmembrane domain of the Semliki Forest virus fusion protein are not required for assembly and fusion. Virology 2005, 332, 430–437. [CrossRef] [PubMed]
97. Cymer, F.; Veerappan, A.; Schneider, D. Transmembrane helix-helix interactions are modulated by the sequence context and by lipid bilayer properties. Biochim. Biophys. Acta 2012, 1818, 963–973. [CrossRef] [PubMed]
98. Senes, A.; Engel, D.E.; De Grado, W.F. Folding of helical membrane proteins: The role of polar, GxxxG-like and proline motifs. Curr. Opin. Struct. Biol. 2004, 14, 465–479. [CrossRef] [PubMed]
99. Stelzer, W.; Langosch, D. Sequence-dependent backbone dynamics of a viral fusogen transmembrane helix. Protein Sci. 2012, 21, 1097–1102. [CrossRef] [PubMed]
100. Russ, W.P.; Engelman, D.M. The GxxxG motif: A framework for transmembrane helix-helix association. J. Mol. Biol. 2000, 296, 911–919. [CrossRef] [PubMed]
101. Unterreitmeier, S.; Fuchs, A.; Schaffler, T.; Heym, R.G.; Frishman, D.; Langosch, D. Phenylalanine promotes interaction of transmembrane domains via GxxxG motifs. J. Mol. Biol. 2007, 374, 705–718. [CrossRef] [PubMed]
102. Mao, Y.; Wang, L.; Gu, C.; Herschhorn, A.; Desormeaux, A.; Finzi, A.; Xiang, S.H.; Sodroski, J.G. Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer. Proc. Natl. Acad. Sci. USA 2013, 110, 12438–12443. [CrossRef] [PubMed]
103. Silverman, J.L.; Greene, N.G.; King, D.S.; Heldwein, E.E. Membrane requirement for folding of the herpes simplex virus 1 gB cytodomain suggests a unique mechanism of fusion regulation. J. Virol. 2012, 86, 8171–8184. [CrossRef] [PubMed]
104. Cai, W.H.; Gu, B.; Person, S. Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J. Virol. 1988, 62, 2596–2604. [PubMed]
105. Baghian, A.; Huang, L.; Newman, S.; Jayachandra, S.; Kousoulas, K.G. Truncation of the carboxy-terminal 28 amino acids of glycoprotein B specified by herpes simplex virus type 1 mutant amb1511-7 causes extensive cell fusion. J. Virol. 1993, 67, 2396–2401. [PubMed]
106. Diakidi-Kosta, A.; Michailidou, G.; Kontogounis, G.; Sivropoulou, A.; Arsenakis, M. A single amino acid substitution in the cytoplasmic tail of the glycoprotein B of herpes simplex virus 1 affects both syncytium formation and binding to intracellular heparan sulfate. Virus Res. 2003, 93, 99–108. [CrossRef]
107. Gage, P.J.; Levine, M.; Glorioso, J.C. Syncytium-inducing mutations localize to two discrete regions within the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B. J. Virol. 1993, 67, 2191–2201. [PubMed]
108. Nixdorf, R.; Klupp, B.G.; Karger, A.; Mettenleiter, T.C. Effects of truncation of the carboxy terminus of pseudorabies virus glycoprotein B on infectivity. J. Virol. 2000, 74, 7137–7145. [CrossRef] [PubMed]
109. Garcia, N.J.; Chen, J.; Longnecker, R. Modulation of Epstein-Barr virus glycoprotein B (gB) fusion activity by the gB cytoplasmic tail domain. MBio 2013, 4, e00571–e00612. [CrossRef] [PubMed]
110. Heineman, T.C.; Hall, S.L. Role of the varicella-zoster virus gB cytoplasmic domain in gB transport and viral egress. J. Virol. 2002, 76, 591–599. [CrossRef] [PubMed]
111. Chowdary, T.K.; Heldwein, E.E. Syncytial phenotype of C-terminally truncated herpes simplex virus type 1 gB is associated with diminished membrane interactions. J. Virol. 2010, 84, 4923–4935. [CrossRef] [PubMed]
112. Chen, J.; Zhang, X.; Jardetzky, T.S.; Longnecker, R. The Epstein-Barr virus (EBV) glycoprotein B cytoplasmic C-terminal tail domain regulates the energy requirement for EBV-induced membrane fusion. J. Virol. 2014, 88, 11686–11695. [CrossRef] [PubMed]
113. Rogalin, H.B.; Heldwein, E.E. The interplay between the HSV-1 gB cytodomain and the gH cytotail during cell-cell fusion. J. Virol. 2015. [CrossRef] [PubMed]
114. Waning, D.L.; Russell, C.J.; Jardetzky, T.S.; Lamb, R.A. Activation of a paramyxovirus fusion protein is modulated by inside-out signaling from the cytoplasmic tail. Proc. Natl. Acad. Sci. USA 2004, 101, 9217–9222. [CrossRef] [PubMed]
115. Aguilar, H.C.; Anderson, W.F.; Cannon, P.M. Cytoplasmic tail of Moloney murine leukemia virus envelope protein influences the conformation of the extracellular domain: Implications for mechanism of action of the R Peptide. J. Virol. 2003, 77, 1281–1291. [CrossRef] [PubMed]
116. Kirchmeier, M.; Fluckiger, A.C.; Soare, C.; Bozic, J.; Ontsouka, B.; Ahmed, T.; Diress, A.; Pereira, L.; Schodel, F.; Plotkin, S.; Dalba, C.; Klatzmann, D.; Anderson, D.E. Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity. Clin. Vaccine Immunol. 2014, 21, 174–180. [CrossRef] [PubMed]
117. Loving, R.; Wu, S.R.; Sjoberg, M.; Lindqvist, B.; Garoff, H. Maturation cleavage of the murine leukemia virus Env precursor separates the transmembrane subunits to prime it for receptor triggering. Proc. Natl. Acad. Sci. USA 2012, 109, 7735–7740. [CrossRef] [PubMed]
118. Chen, J.; Kovacs, J.M.; Peng, H.; Rits-Volloch, S.; Lu, J.; Park, D.; Zablowsky, E.; Seaman, M.S.; Chen, B. Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein. Science 2015, 349, 191–195. [CrossRef] [PubMed]
119. Fan, Q.; Longnecker, R.; Connolly, S.A. A functional interaction between herpes simplex virus 1 glycoprotein gH/gL domains I and II and gD is defined by using alphaherpesvirus gH and gL chimeras. J. Virol. 2015, 89, 7159–7169. [CrossRef] [PubMed]
120. Harman, A.; Browne, H.; Minson, T. The transmembrane domain and cytoplasmic tail of herpes simplex virus type 1 glycoprotein H play a role in membrane fusion. J. Virol. 2002, 76, 10708–10716. [CrossRef] [PubMed]
121. Wilson, D.W.; Davis-Poynter, N.; Minson, A.C. Mutations in the cytoplasmic tail of herpes simplex virus glycoprotein H suppress cell fusion by a syncytial strain. J. Virol. 1994, 68, 6985–6993. [PubMed]
122. Browne, H.M.; Bruun, B.C.; Minson, A.C. Characterization of herpes simplex virus type 1 recombinants with mutations in the cytoplasmic tail of glycoprotein H. J. Gen. Virol. 1996, 77, 2569–2573. [CrossRef] [PubMed]
123. Silverman, J.L.; Heldwein, E.E. Mutations in the cytoplasmic tail of herpes simplex virus 1 gH reduce the fusogenicity of gB in transfected cells. J. Virol. 2013, 87, 10139–10147. [CrossRef] [PubMed]
124. Yang, E.; Arvin, A.M.; Oliver, S.L. The cytoplasmic domain of varicella-zoster virus glycoprotein H regulates syncytia formation and skin pathogenesis. PLoS Pathog. 2014, 10. [CrossRef] [PubMed]
125. Kamen, D.E.; Gross, S.T.; Girvin, M.E.; Wilson, D.W. Structural basis for the physiological temperature dependence of the association of VP16 with the cytoplasmic tail of herpes simplex virus glycoprotein H. J. Virol. 2005, 79, 6134–6141. [CrossRef] [PubMed]
126. Jackson, J.O.; Lin, E.; Spear, P.G.; Longnecker, R. Insertion mutations in herpes simplex virus 1 glycoprotein H reduce cell surface expression, slow the rate of cell fusion, or abrogate functions in cell fusion and viral entry. J. Virol. 2010, 84, 2038–2046. [CrossRef] [PubMed]